Drug makers, eyeing Viagra's runaway success with profit envy, expect the drive for arthritis relief will yield the next wonder drug. Some industry experts believe Celebra, a painkiller that cuts inflammation but avoids the stomach-damaging effects of aspirin, ibuprofen and acetaminophen, could outsell the impotency drug by millions of dollars a year.